Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
97.01-0.57 (-0.58%)
At close: 04:00PM EST
97.02 +0.01 (+0.01%)
After hours: 07:45PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
1,035,891
421,712
32,528
21,351
18,730
Cost of revenue
205,171
89,807
14,107
10,697
8,551
Gross profit
830,720
331,905
18,421
10,654
10,179
Operating expenses
Research development
21,331
11,580
6,537
5,534
4,223
Selling general and administrative
57,590
30,167
12,312
10,190
9,438
Total operating expenses
79,718
41,747
18,849
15,724
13,661
Operating income or loss
751,002
290,158
-428
-5,070
-3,482
Income before tax
752,973
291,684
409
-4,636
-3,001
Income tax expense
186,218
72,532
43
36
-1,015
Income from continuing operations
568,869
214,310
-411
-5,607
-2,510
Net income
569,332
214,310
-411
-5,607
-2,510
Net income available to common shareholders
569,332
214,310
-411
-5,607
-2,510
Basic EPS
-
9.44
-0.02
-0.25
-0.15
Diluted EPS
-
8.91
-0.02
-0.25
-0.15
Basic average shares
-
22,694
18,709
17,978
17,739
Diluted average shares
-
24,056
18,709
17,978
17,739
EBITDA
-
293,120
1,679
-2,907
-1,754